Who are the top shareholders of the Thirumalai Chem.?

The top shareholders of Thirumalai Chem. include Ultramarine And Pigments Ltd at 19.97%, individual investors with 44.83%, and the highest public shareholder, Shivani Tejas Trivedi, at 3.65%. Additionally, 51 Foreign Institutional Investors hold 1.97%, and 6 mutual fund schemes account for 0.72% of the shares, with no pledged promoter holdings reported.

The top shareholders of Thirumalai Chem. include Ultramarine And Pigments Ltd, which holds the largest stake at 19.97%. Following that, individual investors collectively own 44.83% of the shares. The highest public shareholder is Shivani Tejas Trivedi, with a holding of 3.65%. Additionally, the company has 51 Foreign Institutional Investors (FIIs) holding 1.97% and 6 mutual fund schemes that account for 0.72% of the shares. There are no pledged promoter holdings reported.

Who are in the management team of Thirumalai Chem.?

As of March 2022, the management team of Thirumalai Chem includes R Parthasarathy (Chairman & Managing Director), Ramya Bharathram (Managing Director & CFO), and several independent and non-executive directors, totaling 12 key members. This diverse team oversees the company's governance and strategic direction.

As of March 2022, the management team of Thirumalai Chem includes the following individuals:<BR><BR>1. R Parthasarathy - Chairman & Managing Director<BR>2. T Rajagopalan - Company Secretary & Compliance Officer<BR>3. R Sampath - Non-Executive Director<BR>4. Raj Kataria - Independent Director<BR>5. Ravi Shankar - Independent Director<BR>6. Dhruv Moondhra - Independent Director<BR>7. Ramya Bharathram - Managing Director & CFO<BR>8. P Mohanachandra Nair - Non-Executive Director<BR>9. Arun Ramanathan - Independent Director<BR>10. Rajeev M Pandia - Independent Director<BR>11. Bhama Krishnamurthy - Independent Director<BR>12. Arun Alagappan - Independent Director<BR><BR>This team comprises a mix of executive, non-executive, and independent directors, contributing to the governance and strategic direction of the company.

Has Thirumalai Chem. declared dividend?

Yes, Thirumalai Chemicals Ltd has declared a 100% dividend, amounting to ₹1 per share, with an ex-date of July 16, 2024. The dividend yield is 0.37%, and total returns have varied across periods, showing significant growth over the last 5 years.

Thirumalai Chemicals Ltd has declared a 100% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 100%<BR>- Amount per share: 1 per share<BR>- Ex-date: 16 Jul 24<BR><BR>Dividend Yield: 0.37%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -29.55%, with a dividend return of 0%, resulting in a total return of -29.55%.<BR><BR>Over the past year, the price return was 4.74%, the dividend return was 0.35%, leading to a total return of 5.09%.<BR><BR>In the last 2 years, the price return was 41.29%, with a dividend return of 1.28%, culminating in a total return of 42.57%.<BR><BR>For the 3-year period, the price return was 4.34%, the dividend return was 2.10%, resulting in a total return of 6.44%.<BR><BR>In the 4-year span, the price return was 102.08%, with a dividend return of 3.73%, leading to a total return of 105.81%.<BR><BR>Over the last 5 years, the price return was 514.71%, and the dividend return was 10.06%, resulting in a total return of 524.77%.<BR><BR>Overall, Thirumalai Chemicals Ltd has declared a significant dividend, which is reflected in the dividend yield. The total returns over various periods show a mixed performance, with notable growth over the longer term, particularly in the 5-year period.

Who are the peers of the Thirumalai Chem.?

Thirumalai Chem.'s peers include Tata Chemicals, Chemplast Sanmar, India Glycols, GHCL, Fischer Medical, Blue Pearl Agri, J.G.Chemicals, I G Petrochems, and Amines & Plast. In terms of management risk, growth, and capital structure, Thirumalai Chem. is rated average, with a 1-year return of 6.92%, significantly lower than India Glycols' 150.27%.

Peers: The peers of Thirumalai Chem. are Tata Chemicals, Chemplast Sanmar, India Glycols, GHCL, Fischer Medical, Blue Pearl Agri, J.G.Chemicals, I G Petrochems, and Amines & Plast.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL and Chemplast Sanmar, while Average management risk is found at Tata Chemicals, India Glycols, Thirumalai Chem., J.G.Chemicals, I G Petrochems, and Amines & Plast. Below Average management risk is noted at Fischer Medical. Growth is rated as Below Average for Tata Chemicals, Chemplast Sanmar, India Glycols, Thirumalai Chem., Fischer Medical, Blue Pearl Agri, and Amines & Plast., while GHCL shows Good growth. J.G.Chemicals and I G Petrochems have Excellent capital structure, while Average capital structure is found at Tata Chemicals, Thirumalai Chem., and Fischer Medical. Below Average capital structure is noted for Chemplast Sanmar, India Glycols, and Amines & Plast.<BR><BR>Return Snapshot: India Glycols has the highest 1-year return at 150.27%, while Blue Pearl Agri has the lowest return, which is not available. Thirumalai Chem.'s 1-year return is 6.92%, which is significantly lower than India Glycols. Additionally, the six-month returns for Tata Chemicals, Chemplast Sanmar, Blue Pearl Agri, and I G Petrochems are negative.

Is Thirumalai Chem. overvalued or undervalued?

As of February 7, 2024, Thirumalai Chemicals is considered overvalued with a risky valuation grade, reflected by a PE ratio of -60.28 and an EV to EBITDA of 86.21, while its stock has underperformed the Sensex year-to-date but shows significant long-term gains of 506.69%.

As of 7 February 2024, the valuation grade for Thirumalai Chemicals has moved from very expensive to risky. The company is currently assessed as overvalued. Key ratios indicate significant concerns, with a PE ratio of -60.28, an EV to EBITDA of 86.21, and a ROE of -3.99%. <BR><BR>In comparison to its peers, Thirumalai Chem. stands out negatively; for instance, Solar Industries has a PE ratio of 123.77, while Godrej Industries shows a more favorable PE of 46.63. The substantial divergence in these ratios highlights Thirumalai's challenging position within the commodity chemicals sector. Notably, while Thirumalai's stock has underperformed the Sensex year-to-date with a return of -15.27% compared to the Sensex's 5.66%, its long-term performance over five years shows a remarkable gain of 506.69%, suggesting potential for recovery if operational issues are addressed.

What does Thirumalai Chem. do?

Thirumalai Chemicals Ltd is a small-cap company that manufactures and markets various chemical products, including Phthalic Anhydride and Tartaric Acid. As of March 2025, it reported net sales of ₹5,231 Cr and a net loss of ₹141 Cr, with a market cap of ₹3,169 Cr.

Overview: <BR>Thirumalai Chemicals Ltd is a small-cap company in the commodity chemicals industry that manufactures and markets various chemical products including Phthalic Anhydride, Maleic Anhydride, Tartaric Acid, and food acids.<BR><BR>History: <BR>Incorporated in 1972, Thirumalai Chemicals Limited has been engaged in the manufacturing and selling of chemicals since its inception. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 5,231 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: -141 Cr (Quarterly Results - Mar 2025) <BR>Market cap: INR 3,169 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 47 <BR>Dividend Yield: 0.35% <BR>Debt Equity: 1.24 <BR>Return on Equity: -3.99% <BR>Price to Book: 2.56<BR><BR>Contact Details: <BR>Address: Thirumalai House Road No 29, Nr Sion Hill Fort Sion (East) Mumbai Maharashtra : 400022 <BR>Tel: 91-22-24017841/43686225/43686200 <BR>Email: thirumalai@thirumalaichemicals.com <BR>Website: http://www.thirumalaichemicals.com

How big is Thirumalai Chem.?

As of 24th July, Thirumalai Chemicals Ltd has a market capitalization of 3,089.00 Cr, with recent Net Sales of 2,049.51 Cr and a Net Profit loss of 46.10 Cr. The company has Shareholder's Funds of 1,155.67 Cr and Total Assets of 3,806.75 Cr as of March 2025.

As of 24th July, <BR><BR>Thirumalai Chemicals Ltd has a market capitalization of 3,089.00 Cr, classifying it as a Small Cap company.<BR><BR>For the latest four quarters, the company reported Net Sales of 2,049.51 Cr and a Net Profit loss of 46.10 Cr.<BR><BR>As of March 2025, the company has Shareholder's Funds amounting to 1,155.67 Cr and Total Assets of 3,806.75 Cr.

Is Thirumalai Chem. technically bullish or bearish?

As of November 4, 2025, Thirumalai Chem. shows a mildly bearish trend, supported by bearish MACD readings and Bollinger Bands, despite some mixed signals from daily moving averages and OBV.

As of 4 November 2025, the technical trend for Thirumalai Chem. has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by the weekly and monthly MACD readings, both indicating a bearish sentiment. The Bollinger Bands also reflect a bearish outlook on both time frames. The KST confirms this bearishness on the weekly and monthly charts. Although the daily moving averages show a mildly bullish signal, the overall trend is overshadowed by the bearish indicators. The OBV presents a mixed picture, being mildly bullish weekly but bearish monthly. Overall, the combination of these indicators suggests a weak bearish sentiment in the current market environment.

When is the next results date for Thirumalai Chem.?

Thirumalai Chem. will announce its results on 08 November 2025.

Thirumalai Chem. will declare its results on 08 November 2025.

Are Thirumalai Chem. latest results good or bad?

Thirumalai Chemicals' latest Q2 FY26 results are concerning, showing a net loss of ₹33.38 crore and a 15.19% decline in revenue year-on-year. This marks the sixth consecutive quarter of losses, raising serious concerns about the company's financial stability.

Thirumalai Chemicals' latest results for Q2 FY26 are concerning and indicate significant financial distress. The company reported a net loss of ₹33.38 crore, which is a drastic decline of 782.62% year-on-year. This marks the sixth consecutive quarter of losses, with cumulative losses exceeding ₹165 crore over this period.<BR><BR>Revenue also fell by 15.19% year-on-year to ₹445.37 crore, reflecting ongoing operational challenges. The operating margin turned negative at -0.82%, a stark contrast to the 4.47% margin reported in the same quarter last year. Additionally, interest costs surged to ₹25.72 crore, representing a 150.44% increase from the previous year, further straining the company's financial position.<BR><BR>Overall, the results highlight a downward spiral in performance, with deteriorating margins, escalating debt, and negative cash flow, raising serious concerns about the company's ability to recover in the current challenging environment.

Should I buy, sell or hold Thirumalai Chem.?

How has been the historical performance of Thirumalai Chem.?

Thirumalai Chem. has shown fluctuating financial performance, with net sales decreasing from 2,083.13 Cr in Mar'24 to 2,049.51 Cr in Mar'25, and a decline in profitability, resulting in a profit after tax of -46.10 Cr in Mar'25. The company also faced increasing liabilities and negative cash flow from operating activities.

Answer:<BR>The historical performance of Thirumalai Chem. shows a fluctuating trend in key financial metrics over the years, with significant changes in revenue and profitability.<BR><BR>Breakdown:<BR>Thirumalai Chem. reported net sales of 2,049.51 Cr in Mar'25, a slight decrease from 2,083.13 Cr in Mar'24 and 2,132.24 Cr in Mar'23, but an increase from 1,998.19 Cr in Mar'22. The total operating income mirrored this trend, reaching 2,049.51 Cr in Mar'25. The company's total expenditure, excluding depreciation, was 2,000.71 Cr in Mar'25, down from 2,032.11 Cr in Mar'24, with raw material costs peaking at 1,552.78 Cr in Mar'25. Operating profit (PBDIT) fell to 69.40 Cr in Mar'25 from 70.36 Cr in Mar'24, while profit before tax turned negative at -40.85 Cr in Mar'25 compared to -34.55 Cr in Mar'24. Consequently, the profit after tax also declined to -46.10 Cr in Mar'25 from -38.79 Cr in Mar'24. The company's total assets increased to 3,806.75 Cr in Mar'25 from 3,320.27 Cr in Mar'24, driven by a rise in long-term borrowings to 1,400.66 Cr. Cash flow from operating activities showed a negative trend, recording -65.00 Cr in Mar'25, down from 237.00 Cr in Mar'24, leading to a net cash outflow of -222.00 Cr in Mar'25. Overall, Thirumalai Chem. has experienced a challenging financial landscape, marked by declining profitability and increasing liabilities.

Which are the latest news on Thirumalai Chem.?

Why is Thirumalai Chem. falling/rising?

As of 04-Dec, Thirumalai Chemicals Ltd's stock price is declining, currently at 230.15, with a total drop of 5.21% over the last six days and significant year-to-date and annual declines of 28.34% and 38.23%, respectively. The stock is underperforming against moving averages and has reported negative financial results, indicating a bearish trend and reduced investor interest.

As of 04-Dec, Thirumalai Chemicals Ltd's stock price is falling, currently at 230.15, reflecting a decrease of 0.5 (-0.22%). The stock has been on a downward trend, having lost value for the last six consecutive days, resulting in a total decline of 5.21% during this period. This decline is further supported by the stock's performance over various time frames, showing a significant drop of 28.34% year-to-date and 38.23% over the past year, while the broader market, represented by the Sensex, has shown positive returns of 9.12% and 5.32% respectively.<BR><BR>The stock is trading below its moving averages across all time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 52.17% compared to the 5-day average, suggesting reduced interest from investors.<BR><BR>Financially, the company has reported very negative results, including a decline in net sales of 1.04% and negative operating profit growth of -276.45% over the last five years. The company has also declared negative results for four consecutive quarters, with a significant fall in profit before tax and profit after tax compared to previous averages. This poor financial performance, coupled with a negative EBITDA and a history of underperformance against benchmarks, contributes to the stock's current downward trajectory.